PTC THERAPEUTICS, INC. — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-02-01

Reporting Person: Utter Christine Marie (SVP, Finance & CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-01	Common Stock	S	368	$56.956	Disposed	17161	Direct
2021-02-02	Common Stock	S	652	$57.64	Disposed	16509	Direct

Footnotes

F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,020 RSUs from a January 29, 2020 grant of 4,080 RSUs.

F2: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020.